[The use of neuroleptics in the treatment of hyperkinetic behavioral disorders in children]. 2018

D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
Burdenko Voronezh State Medical University, Voronezh, Russia.

OBJECTIVE To compare the efficacy of thioridazine and tiapride in treatment of hyperkinetic behavioral disorders (HBD) in children. METHODS The study included 60 children, детей, 42 boys and 18 girls, mean age 8.0±2.0 years. Patients were divided into two equal groups. The duration of the study was 30 days. The Achenbach System of Empirically Based Assessment (ASEBA) was used. Safety was assessed by sedation scores and serum prolactin levels. CONCLUSIONS A positive effect of both drugs was shown. The levels of aggression and delinquency decreased significantly, while a decrease in attention levels was less pronounced. Both drugs were similar by efficacy, but tiapride had better safety profile.

UI MeSH Term Description Entries
D008297 Male Males
D008571 Men Human males as cultural, psychological, sociological, political, and economic entities. Boys
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002652 Child Behavior Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available. Behavior, Child
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000374 Aggression Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism. Aggressions
D000987 Antisocial Personality Disorder A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994). Antisocial Behavior,Deviant Behavior,Dyssocial Behavior,Personality Disorder, Antisocial,Psychopathic Personality,Sociopathic Personality,Antisocial Personality,Antisocial Behaviors,Antisocial Personalities,Antisocial Personality Disorders,Behavior, Antisocial,Behavior, Deviant,Behavior, Dyssocial,Behaviors, Antisocial,Behaviors, Deviant,Behaviors, Dyssocial,Deviant Behaviors,Disorder, Antisocial Personality,Disorders, Antisocial Personality,Dyssocial Behaviors,Personalities, Antisocial,Personalities, Psychopathic,Personalities, Sociopathic,Personality Disorders, Antisocial,Personality, Antisocial,Personality, Psychopathic,Personality, Sociopathic,Psychopathic Personalities,Sociopathic Personalities
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
April 2014, JAMA pediatrics,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
January 2010, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
January 2002, Praxis der Kinderpsychologie und Kinderpsychiatrie,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
July 1988, Journal of the American Geriatrics Society,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
June 1976, Clinical pediatrics,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
September 1996, Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
June 1961, Revue canadienne de biologie,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
September 2009, The Lancet. Neurology,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
February 1990, Neurologic clinics,
D N Priputnevich, and V A Kutashov, and D A Chernih, and E V Siromyatnikova, and D O Kuptcova
July 1978, The American journal of orthopsychiatry,
Copied contents to your clipboard!